AiM Medical Robotics
AiM Medical Robotics is a pre-revenue medical device company developing an MRI-compatible intraoperative robotic platform for stereotactic neurosurgery, targeting hospitals and neurosurgical centers performing procedures such as deep brain stimulation, tumor ablation, and biopsy.
- Company typePrivate
- Founded2018
- HeadquartersWorcester, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What AiM Medical Robotics does
AiM Medical Robotics is a private medical device company developing an MRI-compatible intraoperative robotic platform for stereotactic neurosurgery. Founded in 2018 and headquartered in Worcester, Massachusetts, the company builds a robotic system engineered to operate within the bore of an MRI scanner, enabling real-time, image-guided procedures such as deep brain stimulation lead placement, tumor ablation, tissue biopsy, and epilepsy interventions. Its core technical differentiation is bidirectional software integration with Siemens Healthineers' MAGNETOM MRI scanners (0.55T to 3T), which supports coordinated robot-MRI workflows for in-bore precision targeting. Leadership combines robotics commercialization experience (Dr. Yulun Wang, Board; previously Computer Motion and InTouch Health) with clinical neurosurgery expertise (Dr. Julie Pilitsis as co-founder/Chief Medical Advisor and Dr. Jonathan Sackier as CMO).
The company is pre-revenue and pre-regulatory-clearance, targeting acute care hospitals and specialized neurosurgical centers as its end customers. Its go-to-market plan combines direct enterprise sales with an OEM-style integration channel via the Siemens Healthineers partnership. Total disclosed funding is approximately $11.3 million across a $3.4M seed (March 2022, led by IQ Capital and Surrey Capital Partners), a Sontag Foundation grant (August 2022), and an $8.1M Series A (September 2025, led by IQ Capital and 1540 Ventures). Proceeds are earmarked for first-in-human clinical trials and regulatory milestones. Revenue mechanics, once commercialized, are expected to follow a capital equipment hardware sales model with professional services for installation, training, and support; pricing is quote-based and not publicly disclosed.
The company addresses a sizable but currently undersized specialized market: the global robotic neurosurgery market was reported at $405.6M in 2024 with a 15.7% CAGR projection to $1.67B by 2034, while its broader target procedures in neurostimulation and neurosurgery represent a $7.9B–$10B initial addressable opportunity. The company's competitive position rests on its MRI-compatible architecture and OEM partnership with Siemens Healthineers, with regulatory progress and clinical execution as the key forward catalysts.
AiM Medical Robotics firmographics
Firmographics- Name
- AiM Medical Robotics
- Legal name
- AiM Medical Robotics Inc.
- Website
- https://aimmedicalrobotics.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AiM Medical Robotics is a pre-revenue medical device company developing an MRI-compatible intraoperative robotic platform for stereotactic neurosurgery, targeting hospitals and neurosurgical centers performing procedures such as deep brain stimulation, tumor ablation, and biopsy.
- Ownership category
- akta.pro rank
AiM Medical Robotics industry classification
Industry- Product category
- Surgical Robotics — MRI-Compatible Neurosurgery Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Medical Imaging AI (HDAAAEAH), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where AiM Medical Robotics is headquartered
LocationHeadquarters
- HQ city
- Worcester
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
AiM Medical Robotics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of MRI-compatible surgical robotics systems to hospitals and neurosurgical centers. The company is working toward regulatory clearance and commercial launch of its neurosurgical robotics platform.
- Professional Services: Implementation, training, and support services for the neurosurgical robotics platform deployment in clinical settings.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
AiM Medical Robotics product offering
Product offeringCore offering
AiM Medical Robotics is developing an MRI-compatible robotic stereotactic neurosurgery system designed to perform neurosurgical procedures directly inside MRI environments. The platform integrates with Siemens Healthineers MAGNETOM MRI scanners (0.55T to 3T) via a proprietary software interface that enables bidirectional control and data exchange, supporting real-time, image-guided procedures such as neurostimulation lead placement for Parkinson's disease, tumor ablation, and biopsies.
Product overview
AiM Medical Robotics offers a single core product: an MRI-compatible robotic neurosurgery platform. This platform integrates directly with Siemens Healthineers' MAGNETOM MRI scanners (0.55T to 3T) via a dedicated software interface, enabling real-time, in-bore neurosurgical precision for procedures including neurostimulation electrode placement (for Parkinson's disease, depression, tremors), tumor ablation, and biopsies. The company's initial target market focuses on deep brain stimulation neurostimulator lead placement procedures.
Differentiator
Problem solved
Functional benefit
Products and services
- MRI-Compatible Robotic Neurosurgery Platform An MRI-compatible robotic stereotactic neurosurgery system designed for precise neurosurgical procedures directly within MRI environments, enabling real-time, image-guided operations including neurostimulation lead placement for Parkinson's disease, tumor ablation, and biopsies. The platform integrates with Siemens Healthineers MAGNETOM MRI scanners (0.55T to 3T) via a proprietary software interface for bidirectional control and data exchange.
Quantifiable outcome
- Reduce procedure times
- +2 more outcomes
Companies that use AiM Medical Robotics
Customer profileSegments3 records
Ideal customer profiles2 records
AiM Medical Robotics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
AiM Medical Robotics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Siemens HealthineerscoreCollaboration to develop an interface enabling AiM's MRI-compatible robotic neurosurgery platform to integrate with Siemens Healthineers' MAGNETOM MRI scanners (0.55T to 3T). The software interface enables bidirectional control and data exchange for real-time, in-bore neurosurgical precision and workflow integration.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
AiM Medical Robotics competitors and assessment
Company assessmentDirect peers
- ClearPoint Neuro: ClearPoint Neuro provides MRI-guided navigation systems for neurosurgery, including DBS lead placement and biopsy workflows. It is the most directly comparable peer because both companies target real-time, MRI-compatible neurosurgical interventions and compete for the same hospital neurosurgery customers.
- Synaptive Medical: Synaptive Medical develops MRI-based neurosurgical planning, navigation, and robotic tools (e.g., Modus V, BrightMatter). It competes head-to-head with AiM in image-guided and MRI-integrated neurosurgical procedures, serving the same academic and tertiary neurosurgery centers.
- Renishaw (neuromate): Renishaw's neuromate stereotactic robot is used for functional neurosurgery including DBS electrode placement. It is a direct competitor to AiM in robotic-assisted stereotactic neurosurgery, addressing overlapping indications and customers.
Broad incumbents
- Brainlab: Brainlab is a large, established image-guided surgery and neurosurgery navigation vendor with broad hospital footprint. It competes with AiM in neurosurgical navigation and is increasingly active in surgical robotics, representing an incumbent threat and potential partner/acquirer.
- Zimmer Biomet (ROSA Robotics): Zimmer Biomet's ROSA platform spans neurosurgical and orthopedic robotics. While its primary commercial pull is in spine and cranial robotics, it directly overlaps AiM's neurosurgical robotics positioning and benefits from a much larger commercial and regulatory infrastructure.
- Medtronic (Mazor / StealthStation): Medtronic combines the Mazor spine robotics platform with StealthStation cranial neurosurgery navigation, giving it incumbency in image-guided neurosurgery adjacent to AiM's focus. As a major medtech acquirer, it is also a likely strategic counterpart.
- Stryker (MAKO): Stryker's MAKO surgical robotics platform is the orthopedic analogue to AiM's neurosurgical play and a benchmark for surgical robotics commercial scale. It is relevant as a model for capital-efficient hospital robotics commercialization and as a strategic acquirer of robotics adjacencies.
Emerging players
- Accuray (CyberKnife): Accuray's CyberKnife robotic radiosurgery system competes in image-guided neurosurgical interventions for tumors and functional disorders. It is a partial-overlap peer addressing overlapping clinical use cases via a different modality (radiation rather than physical intervention).
- Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is a robotic guidance platform primarily in spine, with expanding cranial applications. It overlaps AiM in image-guided surgical robotics for hospital neurosurgery and orthopedics and is a comparable scaling-stage medtech robotics player.
Others
- Integra LifeSciences: Integra LifeSciences supplies neurosurgical instruments, dural repair products, and image-guidance adjacencies. It is not a direct robotics competitor but serves the same neurosurgery customers and is a relevant ecosystem participant and potential channel or acquirer.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
AiM Medical Robotics social profiles
Digital presenceAiM Medical Robotics financial estimates
Financial estimateRevenue estimate
Valuation estimate
AiM Medical Robotics leadership team
Management profileNumber of profiles
Profiles6 records
AiM Medical Robotics funding detail
Funding detailFunding overview
Funding rounds4 records
Investors15 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AiM Medical Robotics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AiM Medical Robotics
What does AiM Medical Robotics do?
AiM Medical Robotics is developing an MRI-compatible robotic stereotactic neurosurgery system designed to perform neurosurgical procedures directly inside MRI environments. The platform integrates with Siemens Healthineers MAGNETOM MRI scanners (0.55T to 3T) via a proprietary software interface that enables bidirectional control and data exchange, supporting real-time, image-guided procedures such as neurostimulation lead placement for Parkinson's disease, tumor ablation, and biopsies.
Is AiM Medical Robotics a public or private company?
AiM Medical Robotics is a private company. It is classified as venture growth investor backed and is currently operating.
When was AiM Medical Robotics founded?
AiM Medical Robotics was founded in 2018. It employs 11 to 50 people.
Where is AiM Medical Robotics based?
AiM Medical Robotics is headquartered in Worcester, United States, in the North America region.
How does AiM Medical Robotics make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are professional Services.
Who are AiM Medical Robotics's main competitors?
Direct peers on record are ClearPoint Neuro, Synaptive Medical and Renishaw (neuromate). Broad incumbents are Brainlab, Zimmer Biomet (ROSA Robotics), Medtronic (Mazor / StealthStation) and Stryker (MAKO). Emerging players are Accuray (CyberKnife) and Globus Medical (ExcelsiusGPS). Integra LifeSciences is listed as an others.
Does AiM Medical Robotics have an API?
No public API is recorded for AiM Medical Robotics.
What industry is AiM Medical Robotics in?
AiM Medical Robotics's product category is Surgical Robotics — MRI-Compatible Neurosurgery Systems. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 339112 and its SIC code is 3841.